The PAN Foundation opens new acute myeloid leukemia patient assistance fund

The PAN Foundation today opened a new patient assistance program for Medicare patients with acute myeloid leukemia (AML). Qualifying patients are eligible to receive grants for their out-of-pocket costs associated with their prescribed AML medications.

“The PAN Foundation is pleased to support people living with acute myeloid leukemia,” said PAN President and CEO Daniel Klein. “When people—and their families—receive a diagnosis like AML, the financial implications can be tremendous. We are committed to finding ways to ease those financial burdens, so that people living with acute myeloid leukemia can focus on feeling better, getting through their treatments and hopefully recovering.”

Patients who qualify for the PAN Foundation’s AML program are eligible to receive up to $5,500 per year in financial assistance. Eligible patients must be getting treatment for AML; must reside and receive treatment in the United States; must have Medicare health insurance; and the medication for which they seek assistance must be covered by Medicare and must treat the disease directly. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (, or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday.